German pharmacists strike over funding cuts and staffing reforms
German pharmacists strike over funding cuts and staffing reforms
German pharmacists strike over funding cuts and staffing reforms
Pharmacists across Germany have taken to the streets in five cities to demand better funding and fairer reimbursement rates. The protests, led by major industry associations, also reject plans to let pharmacy technicians run pharmacies without full oversight. Organisers say the changes threaten the quality of healthcare services nationwide.
Over 100,000 people have backed their cause through a public petition, signalling broad support for the campaign.
The demonstrations come as pharmacists warn of growing strain on drug supply chains, which they describe as increasingly unstable. They argue that underfunding has left many pharmacies struggling to maintain essential services, including on-site labs and professional consultations. Industry leaders insist these must remain core features, not optional extras.
At the heart of the dispute is a government proposal to allow pharmacy technicians (PTAs) to operate pharmacies independently. The ABDA and BVpta associations have firmly opposed this, stating that while they support further training for PTAs, the delegation rules go too far. Thomas Preis, head of ABDA, claims Health Minister Nina Warken (CDU) backs their position. Protesters are also pushing for higher fixed reimbursement rates, arguing that current levels fail to cover rising costs. They describe their work as a vital public service and warn that further cuts would jeopardise reliable access to medicines. With no clear resolution in sight, organisers vow to keep fighting for what they call a sustainable future for the profession.
The protests highlight deep concerns over funding, staffing, and the role of pharmacies in Germany's healthcare system. Nearly 17,000 pharmacies operate nationwide, and industry groups stress that without urgent changes, service quality will decline. The government has yet to respond directly to the latest demonstrations.
Untreated gum disease may double Alzheimer's risk over time
Your oral health might hold the key to brain protection. Scientists reveal how neglected gums could silently raise dementia risks decades later.
Sepsis kills nearly 1 in 5 hospitalized U.S. children, study reveals
One in seventy-five hospitalized kids develops sepsis—yet despite better tools, death rates haven't budged. Why is this silent killer still winning?
Groundbreaking trial tests twice-yearly injection for stubborn high blood pressure
Could a simple injection every six months transform hypertension care? Roche's $300M-backed trial seeks answers for patients who struggle with current treatments.
Malaysia's medicine supply stays stable amid West Asia tensions in 2026
How is Malaysia safeguarding its drug supply during geopolitical unrest? A task force, stockpiles, and real-time tracking keep shortages at bay.